SaNOtize's Anti-Viral Treatment Made Available in Israeli Pharmacie
From BusinessWire: https://www.businesswire.com/news/home/20210708005228/en/SaNOtize%E2%80%99s-Anti-Viral-Treatment-Made-Available-in-Israeli-Pharmacies
VANCOUVER, British Columbia--(BUSINESS WIRE)--SaNOtize Research and Development Corporation (“SaNOtize” or “the Company”) today announced that Enovid, SaNOtize’s Nitric Oxide Nasal Spray (NONS) that protects from viruses and was shown to reduce SARS-CoV-2 viral load in a Phase II trial, is now available in pharmacies throughout Israel.
Enovid was granted an emergency use authorization as a medical device by Israel’s Ministry of Health earlier this year. Enovid provides a physical and chemical barrier to protect from viruses. Enovid releases a small dose of nitric oxide (NO), a natural nanomolecule with proven anti-microbial properties including against SARS-CoV-2, the virus that causes COVID-19.
“We are thrilled to have Enovid available in pharmacies in Israel and we are moving as quickly and diligently as possible through regulatory approval processes elsewhere in the world to make NONS available to the wider public,” said Dr. Chris Miller, SaNOtize Co-founder and Chief Science Officer. “NONS was shown to reduce viral load, which decreases a person’s viral transmission, regardless of variant.”
More info: SaNOtize Research & Development Corp. is a biotech company based in Vancouver, BC working to commercialize the multi-faceted antimicrobial properties of a liquid producing nitric oxide. The company has developed and patented a Nitric Oxide Releasing Solution platform technology (NORSTM) to treat and prevent microbial infections.
